Skip to content

Clinical trials

End Stage Liver Disease trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: End Stage Liver Disease Phase: Not applicable Country / region: United States Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20061
20111
20131
20141
20163
20171
20187
20192
20202
20211
20224
20231
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated4
Recruiting4
Active, not recruiting2
Suspended1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital3
University of Pennsylvania3
Albert Einstein Healthcare Network2
Johns Hopkins University2
Mayo Clinic2
University of California, San Francisco2
University of Washington2
Vanderbilt University Medical Center2
Bridge to Life Ltd.1
Duke University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
End Stage Liver Disease30
Fibrosis10
Heart Failure5
Kidney Failure, Chronic5
Liver Cirrhosis5
Sarcopenia5
Pulmonary Disease, Chronic Obstructive4
Ascites3
Dementia3
Neoplasms3

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.